Covid-19: Vaccine Likely To Be Priced Between Rs 1000 – Rs 5000

Oxford-AstraZeneca, Moderna Inc, Pfizer Inc-BioNTech and Chinese firm Sinovac are all undergoing Phase III trials at present for developing Covid-19 vaccine.. These four are prime candidates for developing vaccine